This is a preview of subscription content, log in via an institution to check access.
Notes
Sorafenib Versus Radioembolization in Advanced Hepatocellular Carcinoma
Reference
Zarca K, et al. Cost-Utility Analysis of Transarterial Radioembolization With Yttrium-90 Resin Microspheres Compared With Sorafenib in Locally Advanced and Inoperable Hepatocellular Carcinoma. Clinical Therapeutics : 3 Jun 2021. Available from: URL: https://doi.org/10.1016/j.clinthera.2021.04.018
Rights and permissions
About this article
Cite this article
Transarterial embolisation not cost effective vs sorafenib for hepatocellular carcinoma. PharmacoEcon Outcomes News 880, 31 (2021). https://doi.org/10.1007/s40274-021-7789-6
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40274-021-7789-6